Abstract Details

Title Design of a Phase 3 Trial to Evaluate the Long-Term Efficacy and Safety of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy

Topic Child Neurology and Developmental Neurology

Presentation(s) P2 - (-)

Poster/Presentation
Number 329

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Panayiota Trifillis PRESENTER	Panayiota Trifillis has received personal compensation for serving as an employee of PTC Therapeutics. Panayiota Trifillis has received stock or an ownership interest from PTC Therapeutics, Inc.. Panayiota Trifillis has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file